M3, Inc. (MTHRF) Stock

About M3, Inc.

M3, Inc., a Japanese corporation established in 2000 and headquartered in Tokyo, primarily delivers internet-based services to physicians and other healthcare professionals. Its operations are strategically divided into five key segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The company manages an extensive portfolio of digital platforms tailored for medical practitioners. This includes m3.com, an exclusive online portal offering healthcare information, and MR-kun, which enables member doctors to continuously access updates and content from the m3com system. QOL-kun further supports members with non-medical, life-enhancement information. For the general public, M3 operates AskDoctors, where registered medical experts address health and illness inquiries. On an international scale, the company provides MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., which assists pharmaceutical companies and hosts drug information databases across France, Germany, and Spain. Additionally, M3 supports career development for doctors and pharmacists through its m3com CAREER service. Beyond these online platforms, M3, Inc. engages in a wide array of activities within the medical and pharmaceutical sectors. This encompasses sales and marketing initiatives for pharmaceuticals and medical devices, along with the development, distribution, and maintenance of electronic medical records and equipment for healthcare institutions. The company also conducts surveys for medical professionals, offers online sales and marketing support to pharmaceutical firms, provides management consulting and assistance to medical facilities, operates home-visit nursing services, delivers human resources solutions for the healthcare industry, and manages clinical trial facilities. Originally incorporated as So-netM3, Inc., the company officially rebranded to M3, Inc. in January 2010.

M3, Inc. is headquartered in JP.

M3, Inc. (MTHRF) stock trades at $8.55 with a market capitalization of $5.71B. The stock is valued at a price-to-earnings (P/E) ratio of 25.36, price-to-book of 3.02, price-to-sales of 3.49. Over the past 52 weeks the stock has ranged between $8.55 and $15.25, and currently trades 43.9% below its 52-week high. It pays a dividend yielding 1.64%.

On profitability, M3, Inc. generates a return on equity (ROE) of 12.38%, above the typical market average, return on capital employed of 13.05%, an operating margin of 19.95%, a net profit margin of 13.97%.

Official website: corporate.m3.com